Palonosetron Hydrochloride/ Fosnetupitant phosphate DP

Helsinn Birex Pharmaceuticals, ltd

Revision date : 2017-07-10

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 4
Safety risk rating 1
Environmental risk rating 1

General Information

Version

1.0.0

Revision date

2017-07-10

Product name

Palonosetron Hydrochloride/ Fosnetupitant phosphate DP

Product name

Palonosetron Hydrochloride/ Fosnetupitant phosphate DP

Identification on the label/Trade name

None identified

Product Synonyms

None identified

Chemical name

Mixture - contains an isoquinoline derivative (palonestron HCl) and a butyramide

1.2.1 Relevant identified uses

Bulk formulated pharmaceutical mixture/ Formulated pharmaceutical product in of the substance or vials; used to treat nausea mixture and uses

Icons in SDS

GHS08

Company Information

company name

Helsinn Birex Pharmaceuticals, ltd

e-mail address of the competent person responsible for the Safety Data Sheet

sds-query@helsinn.com

GHS Information

Signal word

Warning

Hazard Codes

Hazard statements (CLP)

H361d

Hazard statements

Code

Statements

H361d

Suspected of damaging the unborn child.

Section 2

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

substance or mixture Globally Harmonized Reproductive Toxicity - Category 2. System [GHS] Other/Supplemental Mixture not yet fully tested

2.2 Label elements

SECTION 2 - HAZARDS IDENTIFICATION …continued

Signal word

Warning

Hazard statements

H361d - Suspected of damaging the unborn child. precautions have been read and understood. P280 - Wear protective gloves/eye protection/face protection. P308 + P313 - IF exposed or concerned: get medical advice/attention. P405 - Store locked up. P501 - Dispose of contents/container to location in accordance with local/regional/national/international regulations.

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety

2.3 Other hazards

Contains active pharmaceutical ingredients that block specific neurotransmitters involved in feelings of nausea, indicated for the treatment of post-chemotherapy nausea and vomiting. Palonosetron hydrochloride (HCl) blocks a specific serotonin receptor and fosnetupitant phosphate is a prodrug that is metabolized to its active form netupitant, an NK1 receptor blocker. Adverse effects were not identified, but are expected be similar to palonosetron hydrochloride/netupitant and may include: headache, constipation, diarrhea, dizziness, transient changes in heart rate, weakness, hyperkalemia (increased blood potassium levels), and anxiety. In clinical trials, IV doses of fosnetupitant 260 mg/ palonosetron HCl 0.25 mg were investigated. Prolongation of the QT interval (a component of the heart's electrical cycle) may also occur with use based on effects observed in non-clinical studies with netupitant and palonosetron at very high doses; this is a known class effect of similar serotonin receptor antagonists. Based on the mechanism of action and effects observed in non-clinical studies in rabbits with netupitant, a potential for palonosetron/fosnetupitant to cause developmental toxicity cannot be excluded in the absence of data. Note This mixture/product is classified as hazardous under GHS as implemented by

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.